Difamilast Completed Phase 2 Trials for Atopic Dermatitis Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT03018691Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
NCT02945657Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis
NCT02914548Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
NCT02068352A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis